26.12.2012 Views

Toxicology of Industrial Compounds

Toxicology of Industrial Compounds

Toxicology of Industrial Compounds

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

19<br />

Endocrine <strong>Toxicology</strong> <strong>of</strong> the Thyroid for<br />

<strong>Industrial</strong> <strong>Compounds</strong><br />

CHRISTOPHER K.ATTERWILL and SAMUEL<br />

P.AYLWARD<br />

CellTox Centre, University <strong>of</strong> Hertfordshire, Hatfield, Herts<br />

General introduction<br />

Classification <strong>of</strong> endocrine toxicity<br />

Xenobiotic-induced endocrine dysfunction and toxicity is a common<br />

finding in safety studies and an increasingly important consideration in the<br />

riskassessment process. The effective identification <strong>of</strong> potential endocrine<br />

toxicological effects depends upon xenobiotic effect classification in<br />

relation to normal endocrine function and pathology.<br />

Classifications <strong>of</strong> different types <strong>of</strong> endocrine toxicity have been<br />

proposed in previous publications on this subject. Capen and Martin<br />

(1989) proposed a detailed classification based on clinical endocrine<br />

function and pathology. On the other hand, Baylis and Tunbridge (1985)<br />

proposed a simpler classification based on the adverse endocrine reactions<br />

<strong>of</strong> xenobiotics which are observed clinically. From a toxicological or<br />

preclinical safety testing point <strong>of</strong> view, Atterwill and Flack (1993) favoured<br />

classifying endocrine toxicology <strong>of</strong> xenobiotics in a manner which is<br />

similar in concept to that for classifying other toxicological phenomena<br />

(CIOMS, 1983) taking into account the unique nature <strong>of</strong> the endocrine<br />

system. This is as follows (see also Figure 19.1):<br />

Class 1 Effects which can be predicted from the endocrine pharmacology<br />

<strong>of</strong> compounds. An example would be the oestrogens and progestogens<br />

which have a plethora <strong>of</strong> effects on metabolic parameters in addition to their<br />

actions on oestrogen sensitive target sites when administered at<br />

pharmacological doses (the therapeutic dose levels). Further examples are<br />

certain dopamine and 5-HT antagonists acting on hypothalamic and<br />

pituitary receptors which may disrupt ‘downstream’ endocrine functions.<br />

Class 2 Effects which again can be predicted from the endocrine<br />

pharmacology <strong>of</strong> the compound when administered at doses well in excess<br />

<strong>of</strong> the therapeutic dose level. An example would be adrenal steroid<br />

suppression and general excessive catabolism observed with high dose and

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!